{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-035226","form_type":"8-K/A","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2022-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.759592+00:00","generated_at":"2026-06-24T23:02:38.147094+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Pasithea amends 8-K to extend deadline for Alpha-5 Integrin financials filing","bullets":["Original 8-K filed June 22, 2022 reported acquisition of Alpha-5 Integrin, LLC.","This amendment confirms intent to file acquired company financials within 75 days from June 21, 2022.","Pro forma financial information will also be filed within the same period.","No other changes were made to the original Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-035226","json":"https://secwatch.observer/filing/0001213900-22-035226.json","markdown":"https://secwatch.observer/filing/0001213900-22-035226.md","text":"https://secwatch.observer/filing/0001213900-22-035226.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390022035226/0001213900-22-035226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390022035226/ea162141-8ka_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:02:38.147094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}